Weight problems is arguably the defining well being challenge of the twenty first Century. World Well being Organisation information exhibits that 43% of over-18s are obese, and 16% are overweight. Within the US, the grownup weight problems charge is way greater than the worldwide common, at 43%, with an incalculable affect on the nation’s well being, high quality of life, and financial wellbeing.
There’s a lengthy historical past of medical interventions designed to assist folks management their weight, none of which have halted the rise in weight problems. Nevertheless, the emergence of a number of medication that mimic the impact of the GLP-1 hormone —together with Ozempic, Wegovy, and Mountjaro— might be probably the most promising avenue to this point.
The early indicators of the Ozempic weight reduction period
Predictably, these medication are attracting big business and media consideration. Our Senior Guide, Vivienne Rudd mentioned the affect on the wonder market with Cosmetics Design Europe. Moreover, I used to be not too long ago requested by BBC Information to debate how these medication are affecting consumer-facing industries, how they’re driving the conversations that we’re having with our purchasers at Mintel, and the broader implications for society. Watch the interview under.
This BBC interview barely scratched the floor of what Mintel is already studying concerning the medication’ affect. All through this text, our Mintel Consultants Vivienne Rudd and Jonny Forsyth —our Senior Director of Mintel Meals & Drink— present insights on consumer-facing industries, highlighting the broad-based modifications we’re noticing.
The US leads the best way in terms of using these weight reduction medication, regardless that Ozempic is technically solely accredited as a diabetic remedy within the US. Mintel’s Weight Administration Tendencies Report exhibits that 15% of US adults who’re at the moment making an attempt to handle their weight are utilizing one in every of these medication, and 21% are excited about doing so sooner or later. The medication are much less available in lots of different markets, however client curiosity remains to be big. Within the UK, for instance, 25% of adults could be excited about utilizing injectable weight reduction medication.
As anybody who’s ever struggled to keep up a wholesome weight will affirm, it’s loads simpler (and extra fulfilling) to realize weight than dropping it. We’re surrounded by simply accessible, reasonably priced and scrumptious meals, and busy lives imply that discovering the time and willpower for train is tough. It’s no shock that GLP-1 medication have seized the general public’s creativeness.
Current Mintel analysis covers the affect of GLP-1 medication on the foods and drinks business (shopper entry solely) and our findings level out that earlier makes an attempt to “medicate away” weight problems have failed. The likes of Ozempic might observe an analogous path: preliminary pleasure on the thought of a “magic bullet” adopted by disillusionment.
However the sheer scale of the weight problems disaster signifies that if (and it’s an enormous “if”) the GLP-1 medication do have a sustainable affect on weight management, the affect will go means past well being. From vogue to foodservice to leisure, it’ll have an effect on an enormous section of client spending.
“Each chunk counts”
One concern linked to GLP-1 use is the affect of a discount in meals consumption on vitamin. Merely put, if persons are consuming much less, they should make certain that they’re nonetheless getting the vitamins wanted to keep up their well being.
One specialist vitamin model who’s main within the purposeful meals sector is Abbott and their launch of Protality, a high-protein, low-fat and -carbohydrate shake designed to fight potential muscle loss from treatment utilization.
Dietrary complement firm Herbalife has additionally launched vitamin merchandise designed to assist GLP-1 customers. In retail, world dietary complement retailer GNC was the primary to launch an in-store GLP-1 assist program to fight treatment unwanted side effects.
Nevertheless, there’s one other strategy to this increasing challenge. A number of meals manufacturers are creating meal options in response to the Ozempic period that designed to pack the utmost quantity of vitamin into smaller parts. In Might 2024, Nestlé launched Important Pursuit, a line of meals designed to be a companion to GLP-1 customers, and plant-based frozen meal supply service Day by day Harvest has taken an analogous strategy.
GLP-1 has the potential to rewire a number of sectors
There have been loads of disappointments concerning weight reduction options. Preliminary pleasure fades, and weight problems continues to rise. At Mintel, we aren’t medical professionals, so we can’t choose whether or not GLP-1 medication will observe an analogous trajectory to earlier miracle cures.
Nevertheless, Mintel is an skilled in predicting tendencies in market dynamics, innovation, and client behaviour. Ozempic and related medication can have a huge effect on a number of markets in the event that they ship on present expectations.
Food and drinks can be on the forefront of market disruption
Most clearly, they’ll shift client preferences and innovation within the foods and drinks business. Essentially, GPL-1 medication work by lowering urge for food and cravings and, in flip, lowering the variety of energy that persons are consuming. And the straightforward assumption could be that fewer energy consumed will imply decrease gross sales for foods and drinks manufacturers.
In actuality, although, there’s zero likelihood that meals manufacturers will sit again and watch this taking place. It’s one of the vital relentlessly revolutionary consumer-facing sectors, and people innovation groups are already beginning to reply. The alcohol sector, for instance, exhibits how innovation and premiumisation can protect worth gross sales even the place quantity is falling.
Importantly, manufacturers have some respiration house to formulate the simplest response. Even within the US, solely a minority of customers are utilizing these medication, they usually’re much more area of interest exterior that market. Value, provide chain challenges and regulatory points imply that the complete affect isn’t going to be felt for years. That doesn’t imply that manufacturers can afford to sit down again although, particularly as so most of the doable responses match so properly with present tendencies out there.
“Much less however higher” foods and drinks innovation
GLP-1 medication open up a number of avenues for innovation, a lot of them centering on the concept of “much less, however higher”. Nestlé’s launch of Important Pursuit factors the best way: high-quality, nutrient-dense merchandise designed to ensure that persons are nonetheless getting the vitamin they want even when they’re consuming fewer energy. This concern about sustaining vitamin on a decrease calorie consumption will push by way of into innovation round dietary supplements, and a blurring of the boundaries between pure dietary supplements and purposeful meals.
The affect of GLP-1 medication is prone to be most disruptive within the snacking sector. Manufacturers have been endlessly creative in creating new consumption events and merchandise that fulfill our want for a fast pick-up. GLP-1’s affect on satiety and the reported lowered person cravings will hit routine snackers’ tendency to graze mindlessly.
However once more, “much less however higher” might assist preserve the sector’s worth. Any of us who wrestle with willpower know that that suggestion to “fulfill your cravings with one or two squares of actually good darkish chocolate” is wishful considering. For many people, if that bar of chocolate goes to be opened, then it’s going to be completed in a single sitting. Possibly Ozempic is the willpower enhance we have to eat like a wellbeing influencer lastly?
Importantly, these are all innovation tendencies that Mintel has been monitoring and recommending for a while. Meals as drugs, much less however higher, excessive protein, extra aware snacking – they’re all product positionings that already resonate with customers, whether or not or not they’re utilizing GLP-1 medication. What the likes of Ozempic will do is preserve the momentum of those tendencies.
The wonder and private care business can even be impacted
It’s not simply meals that can be affected. My colleagues on Mintel’s Consulting crew, Vivienne Rudd and Alisha Taylor, have already finished intensive work to grasp and predict the affect on the wonder sector. Particularly, there’s room for innovation to counteract “Ozempic face” – the time period used to explain fast weight reduction’s affect on pores and skin firmness and glow.
Utilizing the US as a take a look at market, they used superior information analytics to trace the prevalence of collagen rising and plumping claims in new magnificence and private care product launches. That evaluation discovered that the claims are nonetheless comparatively area of interest, however that they’re rising considerably.
Challenger manufacturers are already responding. On the Cosmoprof Las Vegas commerce present final yr Vivienne and Alisha noticed examples of merchandise claiming to fight collagen depletion. The large alternative for the business leaders is to make use of their innovation experience to create science-driven formulations, after which their advertising and marketing muscle to boost consciousness of those claims within the broader market.
Trying additional forward: a societal shift?
Whenever you look previous client packaged items (CPG), the affect of GLP-1 medication is much less straightforward to foretell – however arguably much more disruptive. Meals is central to so many areas of the human expertise. It’s not simply gasoline. It’s how we take care of ourselves, and for the folks we love. It’s on the coronary heart of how virtually each tradition socialises. If our angle to meals modifications, then so will a number of industries.
Foodservice and the broader leisure sector, for instance, is already being affected by altering attitudes in direction of alcohol consumption. Within the UK, we’ve seen a transfer away from our conventional emphasis on alcohol-facilitated social actions, and a development within the likes of escape rooms, aggressive socialising, and dessert bars.
Ozempic might result in even higher disruption. Going out for dinner can be a lot much less interesting when half the desk has dramatically lowered appetites and spends the meal pushing a half-finished pizza round their plate.
Need to know extra? Simply ask us
Right here at Mintel, we’re specialists in innovation. We’re already figuring out many of those tendencies by way of our skilled analysts and by monitoring product launches on our world new merchandise database (GNPD). From modifications in ingredient and claims structure to broader scanning of client tendencies, Mintel Consulting will help you establish what’s already taking place in your sector, predict what’s coming subsequent, and perceive what it means for what you are promoting’s technique.
Get in contact at this time with Mintel Consulting to study extra about how we will use our strategies to assist drive your development methods.
Contact a Guide
